BISELCO Awards 15-Year Power Supply Deal To CIPC To Strengthen Palawan’s Energy Security

BISELCO has awarded a 15-year power supply deal to CIPC, aimed at enhancing Palawan’s energy security.

Vivant Hits Record PHP2.3 Billion Core Net Income In 2024 Amid Strong Growth

Vivant Corporation reports a remarkable 20% increase in consolidated core net income for 2024, reaching Php 2.3 billion.

ASUS Zenbook A14: The Lightest Zenbook AI Laptop Is In The Philippines

The Zenbook A14 is setting new standards in the world of lightweight laptops with its remarkable design. #PAGEONExASUS

GALLANT: Inspiring Local Champions, Awakening Global Potential

GALLANT is here to inspire local champions and awaken global potential. The time to step up is now.

DOST Funds P19-M Antibody Tests Study

DOST has allocated PHP19.13 million for a study to validate and evaluate antibody tests for COVID-19.

DOST Funds P19-M Antibody Tests Study

12
12

How do you feel about this story?

Like
Love
Haha
Wow
Sad
Angry

The Department of Science and Technology (DOST) has allocated PHP19.13 million for a study to validate and evaluate antibody tests for coronavirus disease 2019 (Covid-19).

The study, to be led by Leonila Dans of the University of the Philippines-Manila, will generate information on the diagnostic accuracy of rapid antibody tests in diagnosing Covid-19 among those suspected to have the disease, DOST Secretary Fortunato dela Peña said over the weekend.

“The proposal was developed and initiated in response to the following: early diagnosis and isolation of those with Covid-19; determine what proportion of the population has been infected with Covid-19 and have developed antibodies, and understand whether or not the development of antibody translates to immunity against a subsequent infection,” dela Peña said.

The study would need around 225 patients, and has a duration of nine months, he added.

There is no target date yet at the start of the study. He, however, said earlier that a study, even if approved by the DOST for funding, needs the Food and Drug Administration’s approval before it could start. A clinical trial cannot be done without FDA approval, he said.

The budget would be used for personnel services, maintenance, and other operating expenses, he said. Most of the operating expenses would be for laboratory supplies and equipment, kits, transportation of samples, sample processing and analysis, he added. (PNA)